Details for New Drug Application (NDA): 202229
✉ Email this page to a colleague
NDA 202229 describes ACAMPROSATE CALCIUM, which is a drug marketed by Barr Labs Div Teva, Glenmark Pharms Ltd, Mylan, and Zydus Pharms, and is included in four NDAs. It is available from six suppliers. Additional details are available on the ACAMPROSATE CALCIUM profile page.
The generic ingredient in ACAMPROSATE CALCIUM is acamprosate calcium. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acamprosate calcium profile page.
The generic ingredient in ACAMPROSATE CALCIUM is acamprosate calcium. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acamprosate calcium profile page.
Summary for 202229
| Tradename: | ACAMPROSATE CALCIUM |
| Applicant: | Glenmark Pharms Ltd |
| Ingredient: | acamprosate calcium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 202229
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 202229 | ANDA | Major Pharmaceuticals | 0904-7213 | 0904-7213-04 | 30 BLISTER PACK in 1 CARTON (0904-7213-04) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK |
| ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 202229 | ANDA | American Health Packaging | 60687-121 | 60687-121-25 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-121-25) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (60687-121-95) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 333MG | ||||
| Approval Date: | Jul 16, 2013 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
